NL7216281A - - Google Patents

Info

Publication number
NL7216281A
NL7216281A NL7216281A NL7216281A NL7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A
Authority
NL
Netherlands
Application number
NL7216281A
Other versions
NL150101B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7216281A publication Critical patent/NL7216281A/xx
Publication of NL150101B publication Critical patent/NL150101B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL727216281A 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen. NL150101B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
NL7216281A true NL7216281A (cg-RX-API-DMAC10.html) 1973-06-18
NL150101B NL150101B (nl) 1976-07-15

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727216281A NL150101B (nl) 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.

Country Status (21)

Country Link
US (1) US3857891A (cg-RX-API-DMAC10.html)
JP (1) JPS5233621B2 (cg-RX-API-DMAC10.html)
AR (2) AR195896A1 (cg-RX-API-DMAC10.html)
AT (1) AT317182B (cg-RX-API-DMAC10.html)
AU (1) AU475446B2 (cg-RX-API-DMAC10.html)
BE (1) BE790165A (cg-RX-API-DMAC10.html)
CA (1) CA993889A (cg-RX-API-DMAC10.html)
CH (1) CH551371A (cg-RX-API-DMAC10.html)
DK (1) DK134906B (cg-RX-API-DMAC10.html)
ES (1) ES409565A1 (cg-RX-API-DMAC10.html)
FI (1) FI55650C (cg-RX-API-DMAC10.html)
FR (1) FR2163486B1 (cg-RX-API-DMAC10.html)
GB (1) GB1344976A (cg-RX-API-DMAC10.html)
HU (1) HU164953B (cg-RX-API-DMAC10.html)
IE (1) IE37701B1 (cg-RX-API-DMAC10.html)
IL (1) IL40833A (cg-RX-API-DMAC10.html)
NL (1) NL150101B (cg-RX-API-DMAC10.html)
NO (1) NO135244C (cg-RX-API-DMAC10.html)
SE (1) SE393104B (cg-RX-API-DMAC10.html)
YU (2) YU35871B (cg-RX-API-DMAC10.html)
ZA (1) ZA727078B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (cg-RX-API-DMAC10.html) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (cg-RX-API-DMAC10.html) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
NZ211815A (en) * 1984-05-15 1988-11-29 Warner Lambert Co Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
AU8527798A (en) * 1998-07-23 2000-02-14 Ing-Jun Chen Guaiacoxypropanolamine derivatives with alpha/beta-adrenergic blocking activity
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
CA2526730A1 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
BRPI0618379A2 (pt) 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
WO2014202646A1 (en) * 2013-06-19 2014-12-24 Som Innovation Biotech, S.L. Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (cg-RX-API-DMAC10.html) * 1962-11-23
NL301580A (cg-RX-API-DMAC10.html) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
JPS4867232A (cg-RX-API-DMAC10.html) 1973-09-13
AU4918672A (en) 1974-05-23
ZA727078B (en) 1973-06-27
CH551371A (fr) 1974-07-15
FI55650B (fi) 1979-05-31
DE2259489A1 (de) 1973-07-05
JPS5233621B2 (cg-RX-API-DMAC10.html) 1977-08-30
DK134906C (cg-RX-API-DMAC10.html) 1977-06-27
AR195896A1 (es) 1973-11-15
YU35871B (en) 1981-08-31
IE37701L (en) 1973-05-14
DE2259489B2 (de) 1976-02-26
HU164953B (cg-RX-API-DMAC10.html) 1974-05-28
CA993889A (en) 1976-07-27
YU301972A (en) 1981-02-28
NO135244C (cg-RX-API-DMAC10.html) 1977-03-09
GB1344976A (en) 1974-01-23
DK134906B (da) 1977-02-07
NO135244B (cg-RX-API-DMAC10.html) 1976-11-29
FR2163486B1 (cg-RX-API-DMAC10.html) 1976-03-05
AR198442A1 (es) 1974-06-21
ES409565A1 (es) 1975-12-01
AU475446B2 (en) 1976-08-26
AT317182B (de) 1974-08-12
BE790165A (fr) 1973-02-15
IL40833A (en) 1976-01-30
IL40833A0 (en) 1973-01-30
YU36007B (en) 1981-11-13
FR2163486A1 (cg-RX-API-DMAC10.html) 1973-07-27
NL150101B (nl) 1976-07-15
US3857891A (en) 1974-12-31
YU293979A (en) 1981-04-30
IE37701B1 (en) 1977-09-28
SE393104B (sv) 1977-05-02
FI55650C (fi) 1979-09-10

Similar Documents

Publication Publication Date Title
FR2123399B1 (cg-RX-API-DMAC10.html)
CS154207B2 (cg-RX-API-DMAC10.html)
DK138549C (cg-RX-API-DMAC10.html)
FR2121752A1 (cg-RX-API-DMAC10.html)
DK138341C (cg-RX-API-DMAC10.html)
DE2146068B2 (cg-RX-API-DMAC10.html)
FR2122806A5 (cg-RX-API-DMAC10.html)
FR2121719B1 (cg-RX-API-DMAC10.html)
FR2122580A1 (cg-RX-API-DMAC10.html)
FR2123492B1 (cg-RX-API-DMAC10.html)
FR2122364A7 (cg-RX-API-DMAC10.html)
FR2124908A5 (cg-RX-API-DMAC10.html)
FR2125233B1 (cg-RX-API-DMAC10.html)
FR2125525B1 (cg-RX-API-DMAC10.html)
DE2149953B2 (cg-RX-API-DMAC10.html)
FR2103936A5 (cg-RX-API-DMAC10.html)
FI47292B (cg-RX-API-DMAC10.html)
FR2121941A5 (cg-RX-API-DMAC10.html)
DE2159794C3 (cg-RX-API-DMAC10.html)
CS153377B1 (cg-RX-API-DMAC10.html)
CS161269B1 (cg-RX-API-DMAC10.html)
CS162922B1 (cg-RX-API-DMAC10.html)
CS162141B1 (cg-RX-API-DMAC10.html)
CS156121B1 (cg-RX-API-DMAC10.html)
CS157926B1 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: PARKE

V4 Discontinued because of reaching the maximum lifetime of a patent